One additional thought: we’re now about four weeks out from the clinical investigation of the peptide action on covid. There must be some results know to Nugenerex by now, eg they either work or they don’t. I have a hard time believing that Generex is signing LOI’s in far off lands if the investigational evidence suggests that the peptides don’t work. We may not know here in the US given the complicated arrangements with BARDA and the FDA. We may still be in a blackout period of some sort. But the overseas LOI’s...if all the parties are the least bit sane...suggest that there is some reason to move things forward. Without evidence of efficacy why put ink to paper?